Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of Covid-19 vaccine clinical trials - A puzzle with missing pieces
Hang Fai Kwok
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1461-1468
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Food and Chemical Toxicology (2022) Vol. 164, pp. 113008-113008
Open Access | Times Cited: 149
Innate Immune Suppression by SARS-CoV-2 mRNA Vaccinations: The role of G-quadruplexes, exosomes and microRNAs
Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, et al.
Authorea (Authorea) (2022)
Open Access | Times Cited: 69
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis
Zejun Li, Shouhuan Liu, Fengming Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Vaccine allocation policy optimization and budget sharing mechanism using reinforcement learning
David Rey, Ahmed W. A. Hammad, Meead Saberi
Omega (2022) Vol. 115, pp. 102783-102783
Closed Access | Times Cited: 28
Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19
Fang Sun, Chenglin Mu, Hang Fai Kwok, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2348-2355
Open Access | Times Cited: 36
Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review
Nicola Veronese, Mirko Petrović, Athanase Bénétos, et al.
Ageing Research Reviews (2021) Vol. 71, pp. 101455-101455
Open Access | Times Cited: 36
Surveillance of Post-Vaccination Side Effects of COVID-19 Vaccines among Saudi Population: A Real-World Estimation of Safety Profile
Abdulaziz Ibrahim Alzarea, Yusra Habib Khan, Ahmed D. Alatawi, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 924-924
Open Access | Times Cited: 26
A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
Marian S. Boshra, Raghda R. S. Hussein, Marwa Mohsen, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 292-292
Open Access | Times Cited: 16
A recombinant SARS-CoV-2 receptor-binding domain expressed in an engineered fungal strain of Thermothelomyces heterothallica induces a functional immune response in mice
Laura Lazo, Mónica Béquet‐Romero, Gilda Lemos, et al.
Vaccine (2022) Vol. 40, Iss. 8, pp. 1162-1169
Open Access | Times Cited: 15
Current clinical status of new COVID-19 vaccines and immunotherapy
Diksha Nagpal, Shakti Nagpal, Deepak Kaushik, et al.
Environmental Science and Pollution Research (2022)
Open Access | Times Cited: 14
COVID-19 Vaccine Hesitancy in Denmark and Russia: A qualitative typology at the nexus of agency and health capital
Anna Schneider‐Kamp
SSM - Qualitative Research in Health (2022) Vol. 2, pp. 100116-100116
Open Access | Times Cited: 13
Trajectory of COVID-19 vaccine hesitancy post-vaccination and public’s intention to take booster vaccines: A cross-sectional analysis
Muhammad Salman, Tauqeer Hussain Mallhi, Yusra Habib Khan, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 6
Lifestyle-mediated nitric oxide boost to prevent SARS-CoV-2 infection: A perspective
Jun Kobayashi
Nitric Oxide (2021) Vol. 115, pp. 55-61
Open Access | Times Cited: 14
Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis
Recai Türkoğlu, Nesrin Baliç, Tuğçe Kızılay, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103524-103524
Open Access | Times Cited: 8
Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report
Massimiliano Esposito, Giuseppe Cocimano, Fabrizio Vanaria, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 142-142
Open Access | Times Cited: 4
Implications of COVID-19 Pandemic on Pregnancy: Current Status and Controversies
Grace C. Greenberg, Nandini Vishwakarma, Myna Prakash Tirupattur, et al.
COVID (2023) Vol. 3, Iss. 6, pp. 859-873
Open Access | Times Cited: 4
Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
Tianhong Li, Kathy Qian Luo
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4642-4647
Open Access | Times Cited: 7
Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 807-807
Open Access | Times Cited: 6
Knowledge, Attitude, and Acceptance of Sinopharm and AstraZeneca’s COVID-19 Vaccines among Egyptian Population: A Cross-Sectional Study
Marian S. Boshra, Marwa O. Elgendy, Lamiaa N. Abdelaty, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 24, pp. 16803-16803
Open Access | Times Cited: 6
RETRACTED: Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate
Johnny Sung, Ying Liu, Kam-Chau Wu, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 2-2
Open Access | Times Cited: 7
Seroconversion and safety of Covid-19 vaccines in patients with chronic liver disease and liver transplant: A systematic review
Abdel‐Naser Elzouki, Mohamed Nabil Elshafei, Afia Aziz, et al.
Qatar medical journal (2023) Vol. 2023, Iss. 3
Open Access | Times Cited: 2
Sputnik‐V vaccine‐induced panniculitis as a local reactions
Zahra Sahraei, Bahareh Abtahi‐Naeini, Ali Saffaei
Clinical Case Reports (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 4
Many-objective approach based on problem-aware mutation operators for protein encoding
María Victoria Díaz-Galián, Miguel A. Vega‐Rodríguez
Information Sciences (2022) Vol. 613, pp. 376-400
Closed Access | Times Cited: 4
Healthcare 4.0 significance and benefits affirmed by the COVID-19 pandemic
Jameela Al‐Jaroodi, Nader Mohamed
Elsevier eBooks (2022), pp. 307-330
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top